164 results on '"Ramanathan, Lakshmi V."'
Search Results
2. Detection of ovarian cancer via the spectral fingerprinting of quantum-defect-modified carbon nanotubes in serum by machine learning
3. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases
4. Acknowledgments
5. Overview of traditional and nontraditional tumor markers
6. List of contributors
7. Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
8. Abstract 10482: High Sensitivity Troponin I and Myocardial Injury After Noncardiac Surgery in Cancer Patients: A Prospective Observational Cohort Study
9. The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic
10. Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients
11. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
12. Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry
13. Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors
14. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
15. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
16. Evaluation and Management of Testosterone Deficiency: AUA Guideline
17. Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
18. Data from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
19. Supplemental Table 3A&3B from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
20. Supplemental Table 1 from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
21. Supplementary Table and Figures from Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
22. Data from Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
23. Supplemental Table 2A&2B from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
24. Development and validation of a turbulent flow chromatography and tandem mass spectrometry method for the quantitation of methotrexate and its metabolites 7-hydroxy methotrexate and DAMPA in serum
25. Synthetic molecular recognition nanosensor paint for microalbuminuria
26. Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
27. Reducing False-Positive Pregnancy Test Results in Patients With Cancer
28. Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
29. Women in Laboratory Medicine: A Q&A on Diversity and Inclusion
30. Chapter 1 - Overview of traditional and nontraditional tumor markers
31. Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection
32. Development of an Assay for Methotrexate and Its Metabolites 7-Hydroxy Methotrexate and DAMPA in Serum by LC-MS/MS
33. A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives
34. Innate immune signaling drives late cardiac toxicity following DNA damaging cancer therapies
35. Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
36. Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
37. Supplemental Material, sj-pdf-1-apc-10.1177_23742895211006818 - The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic
38. Extreme Hyponatremia: Can We Go below the Analytical Range?
39. Women in Laboratory Medicine: A Q&A on Diversity and Inclusion.
40. Validation of a quality assessment system for blood gas and electrolyte testing
41. Endocrine testing in the operating room
42. Lower Rate of Seropositivity to Measles Among Young Healthcare Personnel in New York City
43. A Doctor Asks the Lab to Send Cyanide to the Intensive Care Unit
44. Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
45. Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay
46. Data to support a simultaneous testosterone and estradiol assay in serum by LC-MS/MS
47. A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives.
48. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection
49. Data from the analytical performance of the Abaxis Piccolo Xpress point of care analyzer in whole blood, serum, and plasma
50. Two cases of spontaneous remission of non-parasitic chyluria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.